Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

<p>Abstract</p> <p>Background</p> <p>To evaluate efficacy and feasibility of chemo-radiotherapy in patients with non-metastatic anal squamous-cell-cancer.</p> <p>Methods</p> <p>TNM staged anal squamous-cell cancer patients were treated with pelvi...

Full description

Bibliographic Details
Main Authors:	Petralia Giuseppe, Fodor Cristiana, Petazzi Elena, Santoro Luigi, Leonardi Maria C, Magni Elena, Zampino Maria G, Trovato Cristina, Nolè Franco, Orecchia Roberto
Format:	Article
Language:	English
Published:	BMC 2011-02-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/11/55

Similar Items

Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
by: Masatsugu Ishii, et al.
Published: (2022-01-01)

Dramatic response to modified docetaxel, cisplatin, and fluorouracil chemotherapy after immunotherapy in a patient with refractory metastatic anal cancer
by: Faisal Shahjehan, et al.
Published: (2019-09-01)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
by: Zhen Zeng, et al.
Published: (2018-10-01)

Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective analysis
by: Sung Won Lee, et al.
Published: (2017-10-01)

Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil
by: Rafael C. Coelho, et al.
Published: (2019-01-01)

Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center
by: Maria Saveria Rotundo, et al.
Published: (2020-07-01)

Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer
by: Jin Ye Fu, et al.
Published: (2023-02-01)

Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Ting Jin, et al.
Published: (2019-04-01)

Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma
by: Xue-Song Sun, et al.
Published: (2020-08-01)

Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma
by: Stefano Kim, et al.
Published: (2022-08-01)

Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
by: Zhao Y, et al.
Published: (2021-01-01)

Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
by: Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tatsuya Okuno, Naoko Chayahara, Ikuya Miki, Takao Tamura, Tsubasa Inokuma, Yoshiji Takemoto, Tsutomu Nakamura, Kazusaburo Kataoka, Toshiyuki Sakaeda
Published: (2009-01-01)

Consolidated Group of Taxpayers: Infusion into the Russian Economic Practice
by: Natalia A. Kondrashova
Published: (2016-09-01)

Consolidated Group of Taxpayers: Infusion into the Russian Economic Practice
by: Natalia A. Kondrashova
Published: (2016-10-01)

Consolidated Group of Taxpayers: Infusion into the Russian Economic Practice
by: Natalia A. Kondrashova
Published: (2016-10-01)

Consolidated Group of Taxpayers: Infusion into the Russian Economic Practice
by: Natalia A. Kondrashova
Published: (2016-10-01)

Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
by: Angélique Saint, et al.
Published: (2019-11-01)

Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study
by: Caroline Gronnier, et al.
Published: (2023-04-01)

Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
by: Ying-Tao Lin, et al.
Published: (2023-11-01)

Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS)
by: Miller, R, et al.
Published: (2003)

Primary pure gastric yolk sac tumor
by: Elena Magni, et al.
Published: (2010-03-01)

Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches
by: Giulia Marvaso, et al.
Published: (2021-08-01)

Impact of preoperative docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy on degree of malignant esophageal stenosis
by: Takahisa Yamaguchi, et al.
Published: (2023-08-01)

Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line
by: Wannisa Khamaikawin, et al.
Published: (2023-12-01)

Low‐dose 5‐fluorouracil/cisplatin therapy as conversion chemotherapy for advanced extramammary Paget's disease
by: Kento Nakamura, et al.
Published: (2020-04-01)

Adjuvant chemoradiotherapy combined with cisplatin, 5-fluorouracil and folinic acid for locally advanced gastric cancer
by: Muharrem Kocar, et al.
Published: (2016-04-01)

Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin.
by: Elaine J Gavin, et al.
Published: (2008-01-01)

Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma
by: Frédéric Fiteni, et al.
Published: (2016-11-01)

Real-World Cost-Effectiveness Analysis of Gemcitabine and Cisplatin Compared to Docetaxel and Cisplatin Plus Fluorouracil Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Jiangping Yang, et al.
Published: (2020-12-01)

Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion
by: Karoline Freeman, et al.
Published: (2015-11-01)

Initial experience with topical fluorouracil (5-FU) for treatment of anal intraepithelial neoplasia (AIN) in HIV-positive patients
by: Aboulafia David M, et al.
Published: (2010-10-01)

Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma
by: Andrew J. Sinnamon, et al.
Published: (2023-09-01)

A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
by: Hark Kyun Kim, et al.
Published: (2011-02-01)

ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma
by: Zhang B, et al.
Published: (2019-01-01)

Delirium and seizures in a patient with head-and-neck squamous cell carcinoma on docetaxel, cisplatin, and 5-fluorouracil
by: Satvik Khaddar, et al.
Published: (2019-01-01)

Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma
by: Zili Hu, et al.
Published: (2023-06-01)

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)
by: Stefano Kim, et al.
Published: (2017-08-01)

Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
by: Arnott, S, et al.
Published: (1996)

The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia
by: Lu Wang, et al.
Published: (2023-10-01)

Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma
by: Laure Hervé, et al.
Published: (2022-11-01)